TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company†or "Organigram†), Canada's #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. ("Phylos†), securing Organigram's position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement, Organigram gains priority access to Phylos' autoflower genetics pipeline, including preferential economic terms and long-ter. ...